Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials-Reference-Cited by-同舟云学术

Can clinicopathological parameters predict for lymph node metastases in ypT0-2 rectal carcinoma? Results of the CAO/ARO/AIO-94 and CAO/ARO/AIO-04 phase 3 trials

Published:2018-09 Issue:3 Volume:128 Page:557-563
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

von den Grün Jens Müller,Hartmann Arndt,Fietkau Rainer,Ghadimi Michael,Liersch Torsten,Hohenberger Werner,Weitz Jürgen,Sauer Rolf,Wittekind Christian,Ströbel Philipp,Rödel Claus,Fokas Emmanouil

Funder

German Cancer Aid

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference55 articles.

1. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012

2. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study;Bosset;Lancet Oncol,2014

3. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–4 rectal cancers: results of FFCD 9203;Gerard;J Clin Oncol,2006

4. Training and quality assurance for rectal cancer: 20 years of data is enough;Quirke;Lancet Oncol,2003

5. Histopathological work-up of resection specimens, local excisions and biopsies in colorectal cancer;Quirke;Digest Dis,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy;Journal of Cancer Research and Clinical Oncology;2024-04-04

2. MRI‐based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy;ANZ Journal of Surgery;2024-01-22

3. Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review;Cancers;2023-12-20

4. Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review;Clinics in Colon and Rectal Surgery;2023-04-09

5. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma;Frontiers in Immunology;2022-09-06